ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 187,65
0,00%
Dow Jones
39 387,76
0,85%
DAX
18 686,60
1,07%
Brent Oil
84,255
0,36%
Bitcoin
62 800,57
-0,39%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
11/01/202408h00RNS Non-RegulatoryHutchmed (China) Limited Sovleplenib NDA Granted Priority Review in ChinaLSE:0J7GHutchison China Meditech Ltd
29/12/202309h30UK RegulatoryHutchmed (China) Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
29/12/202309h30UK RegulatoryHutchmed (China) Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
21/12/202311h00UK RegulatoryHutchmed (China) Limited Overseas Regulatory AnnouncementLSE:0J7GHutchison China Meditech Ltd
13/12/202308h00RNS Non-RegulatoryHutchmed (China) Limited Completed Enrollment of Phase II/III TrialLSE:0J7GHutchison China Meditech Ltd
13/12/202308h00RNS Non-RegulatoryHutchmed (China) Limited Inclusion in National Reimbursement Drug ListLSE:0J7GHutchison China Meditech Ltd
01/12/202308h00RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at CongressesLSE:0J7GHutchison China Meditech Ltd
09/11/202308h00UK RegulatoryHutchmed (China) Limited U.S. FDA Approval of FRUZAQLA(TM) (fruquintinib)LSE:0J7GHutchison China Meditech Ltd
24/10/202310h30UK RegulatoryHutchmed (China) Limited Vesting of awards under the LTIPLSE:0J7GHutchison China Meditech Ltd
16/10/202310h30RNS Non-RegulatoryHutchmed (China) Limited Clinical Data to be Presented at ESMO 2023LSE:0J7GHutchison China Meditech Ltd
29/09/202310h30RNS Non-RegulatoryHutchmed (China) Limited NDA Submission for Fruquintinib in JapanLSE:0J7GHutchison China Meditech Ltd
14/09/202310h30UK RegulatoryHutchmed (China) Limited Director's Share DealingLSE:0J7GHutchison China Meditech Ltd
12/09/202310h30RNS Non-RegulatoryHutchmed (China) Limited Phase IIIb Savolitinib Results at WCLC 2023LSE:0J7GHutchison China Meditech Ltd
12/09/202308h00RNS Non-RegulatoryHutchmed (China) Limited Patient Enrollment Completed for Bridging StudyLSE:0J7GHutchison China Meditech Ltd
29/08/202308h00RNS Non-RegulatoryHutchmed (China) Limited BTD in China for Savolitinib for Gastric CancerLSE:0J7GHutchison China Meditech Ltd
21/08/202308h00UK RegulatoryHutchmed (China) Limited Sovleplenib Phase 3 Study Meets Primary EndpointLSE:0J7GHutchison China Meditech Ltd
07/08/202310h30UK RegulatoryHutchmed (China) Limited Exercise of Share Options by a DirectorLSE:0J7GHutchison China Meditech Ltd
31/07/202313h00UK RegulatoryHutchmed (China) Limited Interim Results and Business UpdatesLSE:0J7GHutchison China Meditech Ltd
20/07/202308h00RNS Non-RegulatoryHutchmed (China) Limited Breakthrough Therapy Designation for FruquintinibLSE:0J7GHutchison China Meditech Ltd
13/07/202310h30UK RegulatoryHutchmed (China) Limited Changes to Board and Technical CommitteeLSE:0J7GHutchison China Meditech Ltd
10/07/202308h00RNS Non-RegulatoryHutchmed (China) Limited Phase 1 Study of HMPL-415 InitiatedLSE:0J7GHutchison China Meditech Ltd
26/06/202310h30UK RegulatoryHutchmed (China) Limited HUTCHMED to Announce 2023 Half-Year ResultsLSE:0J7GHutchison China Meditech Ltd
16/06/202308h00UK RegulatoryHutchmed (China) Limited Phase III FRESCO-2 Results in The LancetLSE:0J7GHutchison China Meditech Ltd
15/06/202316h39UK RegulatoryHutchmed (China) Limited MAA of Fruquintinib Validated by the EMALSE:0J7GHutchison China Meditech Ltd
09/06/202311h30RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at EHA and ICMLLSE:0J7GHutchison China Meditech Ltd
06/06/202311h00UK RegulatoryHutchmed (China) Limited LTIP and Share Option SchemeLSE:0J7GHutchison China Meditech Ltd
26/05/202308h00UK RegulatoryHutchmed (China) Limited Fruquintinib NDA Granted Priority Review by FDALSE:0J7GHutchison China Meditech Ltd
26/05/202308h00RNS Non-RegulatoryHutchmed (China) Limited HUTCHMED Highlights Presentations at ASCO 2023LSE:0J7GHutchison China Meditech Ltd
17/05/202310h30UK RegulatoryHutchmed (China) Limited Standard form for notification of major holdingsLSE:0J7GHutchison China Meditech Ltd
12/05/202314h15UK RegulatoryHutchmed (China) Limited Annual General Meeting Poll ResultsLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

EU
BEL20
Bel 20
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
HO
Thales
EU
AI
Air Liquide
NASDAQ
NVDA
NVIDIA
EU
LR
Legrand
EU
BNP
BNP Paribas
NASDAQ
AMZN
Amazon.com
EU
PX4
SBF 120
EU
VIV
Vivendi
FTSE
UKX
FTSE 100
EU
RNO
Renault
COIN
BTCUSD
Bitcoin
EU
VK
Vallourec
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés